These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders. McCormack PL BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447 [TBL] [Abstract][Full Text] [Related]
9. [Effects and side effects of intravenous gamma globulin I: the problem of immune complex formation]. Tilz GP; Nydegger U Wien Med Wochenschr; 1991; 141(13):301-3. PubMed ID: 1926879 [TBL] [Abstract][Full Text] [Related]
10. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. Berger M; Murphy E; Riley P; Bergman GE; South Med J; 2010 Sep; 103(9):856-63. PubMed ID: 20689467 [TBL] [Abstract][Full Text] [Related]
11. Intravenous immune globulin for treating primary immunodeficiency disease. Miller DS MCN Am J Matern Child Nurs; 1987; 12(4):244-8. PubMed ID: 3112495 [No Abstract] [Full Text] [Related]
12. Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy. Gardulf A; Borte M; Ochs HD; Nicolay U; Clin Immunol; 2008 Jan; 126(1):81-8. PubMed ID: 17964220 [TBL] [Abstract][Full Text] [Related]
13. Intravenous therapy with gamma globulin. Dwyer JM Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246 [TBL] [Abstract][Full Text] [Related]
14. Self-infusion of intravenous immunoglobulin by immunodeficient patients at home. Ochs HD; Lee ML; Fischer SH; Delson ES; Chang BS; Wedgwood RJ J Infect Dis; 1987 Oct; 156(4):652-4. PubMed ID: 3624908 [No Abstract] [Full Text] [Related]
16. [Feasibility of administering Tegeline at home. Retrospective study of efficacy, safety and tolerance]. Debré M; Clairicia M; Bonnaud F; Jubin O; Thiébaux-Boucard D Presse Med; 2004 Jun; 33(10):682-8. PubMed ID: 15257243 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases. Stein MR; Koterba A; Rodden L; Berger M Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101 [TBL] [Abstract][Full Text] [Related]
19. Adverse reactions in selected patients following intravenous infusions of gamma globulin. Day NK; Good RA; Wahn V Am J Med; 1984 Mar; 76(3A):25-32. PubMed ID: 6231860 [TBL] [Abstract][Full Text] [Related]